Peer Review History

Original SubmissionJanuary 15, 2025
Decision Letter - Giuseppe Di Martino, Editor

Dear Dr.  Nong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 31 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Giuseppe Di Martino

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Thank you for asking me to review the manuscript. For ease and compliance for editing, I had to convert and download as MSM instead of PDF.

The manuscript is well written and the information provided is useful to the scientific world. However I wish to observe and suggest as follows:

1. Title: The title may have to be edited as shown in the annotations in the attached suggestion for clarity.

2. Main text: Other errors and suggestions as attached in the annotations in the attachment.

3. Discussion: The first paragraph here is essentially a repetition of the results, so should either be expunged or rephrased.

Reviewer #2: 1.Review the manuscript for some typos.

2. Considering C51-58 as a whole - Since these involve topographies with different risk factors, incidence, and mortality, I suggest that the authors at least present a table with showing rates of each.

3. For the first mortality rates presented in results, Are these crude or age-standardized rates?

4. How was the ASMR calculated and which was the reference population? Describe in methods.

5. Describe in Methods how was the age groups achieved.

6. The authors perform a discussion of risk of individual female reproductive malignancies, but their research did not approach individual topographies. I suggest, some data of individual topographies be given.

7. In limitations, it is said that this is a cross-sectional study. So, I suggest revising.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Matthias Gabriel Abah

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 1

PLOS ONE

April 2025

PONE-D-25-02080

Trend of cancer mortality of the female reproductive system in China from 2005 to 2018 and prediction to 2035: a Log-linear regression and Bayesian age-period- cohort analysis

Dear editor and reviewers,

We appreciate editor and reviewers very much for their positive and constructive comments and suggestions on our manuscript entitled “Trend of cancer mortality of the female reproductive system in China from 2005 to 2018 and prediction to 2035: a Log-linear regression and Bayesian age-period-cohort analysis” (Manuscript ID: PONE-D-25-02080). Those comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our researches. Based on these comments and suggestions, we have made careful modification on the original manuscript.

On the separate pages, we provided our response to the comments and suggestions, point by point, and highlighted the changes in the marked copy of the revision. We hope that our revision will be approved by the experts and reviewed favorably.

Sincerely,

Weixia Nong, MD

Reviewer #1: Thank you for asking me to review the manuscript. For ease and compliance for editing, I had to convert and download as MSM instead of PDF.

The manuscript is well written and the information provided is useful to the scientific world. However I wish to observe and suggest as follows:

1. Title: The title may have to be edited as shown in the annotations in the attached suggestion for clarity.

Response�Thank you for your reasonable suggestions. But we didn't find the attachment. Could you please send it again.

2. Main text: Other errors and suggestions as attached in the annotations in the attachment.

Response�Thank you for your careful review. But we didn't find the attachment. Could you please send it again.

3. Discussion: The first paragraph here is essentially a repetition of the results, so should either be expunged or rephrased.

Response�Thank you for your reasonable suggestions. We have deleted.

Reviewer #2:

1.Review the manuscript for some typos.

Response�Thank you for your careful review. We have checked and modified.

2. Considering C51-58 as a whole - Since these involve topographies with different risk factors, incidence, and mortality, I suggest that the authors at least present a table with showing rates of each.

Response�Thank you for your reasonable advice. We have added the mortality rates of eight female reproductive system cancers in the Supplementary Material (Table S1-S8), and added description in the results: “It was further found that among the female reproductive system cancers, cervical uteri cancer had the highest ASMR (3.34 per 100,000) and placenta cancer had the lowest ASMR (0.01per 100,000) (Table S1-S8).”

3. For the first mortality rates presented in results, Are these crude or age-standardized rates?

Response�Thank you for your careful review. The first mortality rate that emerged in the results was the crude mortality rate, and the age standardized mortality rate was expressed by ASMR.

4. How was the ASMR calculated and which was the reference population? Describe in methods.

Response�Thank you for your reasonable suggestions. We have added in the methods section: “To eliminate the effect of the age structure of the population on the level of death, it is necessary to calculate the age-standardized mortality rate (ASMR), that is, the mortality rate calculated according to the age structure of a certain standard population. In this study, the standard population used was the population composition of the sixth national census in 2010 released by the National Bureau of Statistics of China(20).”

5. Describe in Methods how was the age groups achieved.

Response�Thank you for your reasonable suggestions. We have supplemented in the methods section: “The age groups in this study were divided into one age group at intervals of five years as stated in the Chinese Cancer Registry Annual Report.”

6. The authors perform a discussion of risk of individual female reproductive malignancies, but their research did not approach individual topographies. I suggest, some data of individual topographies be given.

Response�Thank you for your reasonable request. We have added the mortality rates of eight female reproductive system cancers in the Supplementary Material (Table S1-S8).

7. In limitations, it is said that this is a cross-sectional study. So, I suggest revising.

Response�Thank you for your reasonable suggestions. We have deleted.

Attachments
Attachment
Submitted filename: Response to Reviewers.doc
Decision Letter - Yordanis Enríquez Canto, Editor

Dear Dr. Nong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your study provides valuable insights into the mortality trends of female reproductive system cancers in China and employs appropriate statistical methodologies for trend analysis and prediction. The work addresses an important public health issue and will contribute meaningfully to the epidemiological literature. However, minor revisions are required before final acceptance

Required revisions:

The manuscript requires a complete revision of academic writing to enhance clarity, coherence, and overall readability. Please ensure the writing style aligns with scholarly standards.

  1. Discussion - Reference Citation: In the second paragraph of the discussion, you mention "the 2024 edition of the Global Obesity Map released by the World Obesity Federation." Please provide a complete and proper reference citation for this source in your reference list.
  2. Discussion - Third Paragraph: The sentence "These reasons may be due to the increasing trend in the mortality rate of the female reproductive system cancer in urban areas was more pronounced than in rural areas, leading to a narrowing of the mortality gap between urban and rural areas" requires revision for clarity and grammatical correctness. Please, also be mindful of potential ecological fallacy when making causal inferences from population-level data.
  3. Methodological Note: Please acknowledge in your limitations section that the reference population used was China's population, which limits the generalizability of direct rate comparisons to other countries or global contexts.

This decision is based on one reviewer's assessment due to the unavailability of the second reviewer's opinion. The revisions requested are minor and primarily focus on language clarity, proper citation, and methodological transparency.

Please submit your revised manuscript by Aug 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Yordanis Enríquez Canto, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: -In the first paragragh of introduction review the verbal tense following "Cancer... has.

-Only a comment: the reference population used was China's, so worldwide comparisons of rates is not possible.

-2nd. paragraph of discussion: provide a reference for the 2024 edition of the Global Obesity Map.

-The last phrase of 3rd. paragraph in Discussion: "These reasons may be due to the increasing trend..." needs to be rewritten, probably the aforementioned factors may lead to the increasing mortality. However, beware of the so called "ecological fallacy".

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 2

PLOS ONE

June 2025

PONE-D-25-02080

Trend of cancer mortality of the female reproductive system in China from 2005 to 2018 and prediction to 2035: a Log-linear regression and Bayesian age-period- cohort analysis

Dear editor and reviewers,

We appreciate editor and reviewers very much for their positive and constructive comments and suggestions on our manuscript entitled “Trend of cancer mortality of the female reproductive system in China from 2005 to 2018 and prediction to 2035: a Log-linear regression and Bayesian age-period-cohort analysis” (Manuscript ID: PONE-D-25-02080). Those comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our researches. Based on these comments and suggestions, we have made careful modification on the original manuscript.

On the separate pages, we provided our response to the comments and suggestions, point by point, and highlighted the changes in the marked copy of the revision. We hope that our revision will be approved by the experts and reviewed favorably.

Sincerely,

Weixia Nong, MD

Required revisions:

The manuscript requires a complete revision of academic writing to enhance clarity, coherence, and overall readability. Please ensure the writing style aligns with scholarly standards.

Response�We reviewed and improved the full text again to make the expression of this article clearer and more in line with academic standards. Thank you very much to the editors and experts for their careful review and valuable comments.

1.Discussion - Reference Citation: In the second paragraph of the discussion, you mention "the 2024 edition of the Global Obesity Map released by the World Obesity Federation." Please provide a complete and proper reference citation for this source in your reference list.

Response�Thank you for your reasonable suggestions. We have supplemented the references.

2.Discussion - Third Paragraph: The sentence "These reasons may be due to the increasing trend in the mortality rate of the female reproductive system cancer in urban areas was more pronounced than in rural areas, leading to a narrowing of the mortality gap between urban and rural areas" requires revision for clarity and grammatical correctness. Please, also be mindful of potential ecological fallacy when making causal inferences from population-level data.

Response�Thank you for your reasonable suggestions. We strongly agree with this statement. We also recognize that such an explanation is inappropriate, so we have deleted it.

3.Methodological Note: Please acknowledge in your limitations section that the reference population used was China's population, which limits the generalizability of direct rate comparisons to other countries or global contexts.

Response�Thank you for your reasonable suggestions. We have added: “ Also, the fact that these data were obtained from the Chinese population limits the generalizability of direct rate comparisons with other countries or globally.”

Attachments
Attachment
Submitted filename: Response_to_Reviewers_auresp_2.doc
Decision Letter - Yordanis Enríquez Canto, Editor

Trend of cancer mortality of the female reproductive system in China from 2005 to 2018 and prediction to 2035: a Log-linear regression and Bayesian age-period- cohort analysis

PONE-D-25-02080R2

Dear Dr. Nong,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yordanis Enríquez Canto, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: I have no additional points since the authors have addressed them all. I understand the manuscript is now ready to follow the editors commands.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: Yes:  Carlos Anselmo Lima

**********

Formally Accepted
Acceptance Letter - Yordanis Enríquez Canto, Editor

PONE-D-25-02080R2

PLOS ONE

Dear Dr. Nong,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Yordanis Enríquez Canto

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .